Pnc Financial Services Group, Inc. Organogenesis Holdings Inc. Transaction History

Pnc Financial Services Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.97 - $4.21 $23 - $50	12 New	12 $0
Q1 2023 May 15, 2023	SELL	$1.89 - $2.93 $4,715 - $7,310	-2,495 Reduced 89.78%	284 $0
Q4 2022 Feb 10, 2023	SELL	$2.48 - $3.43 $9,867 - $13,647	-3,979 Reduced 58.88%	2,779 $7,000
Q3 2022 Nov 10, 2022	BUY	$3.14 - $6.43 $6,845 - $14,017	2,180 Added 47.62%	6,758 $21,000
Q2 2022 Aug 12, 2022	BUY	$4.74 - $8.15 $5,740 - $9,869	1,211 Added 35.97%	4,578 $22,000
Q1 2022 May 12, 2022	SELL	$6.47 - $9.57 $7,848 - $11,608	-1,213 Reduced 26.48%	3,367 $25,000
Q4 2021 Feb 11, 2022	BUY	$9.02 - $13.5 $20,367 - $30,483	2,258 Added 97.24%	4,580 $42,000
Q3 2021 Nov 05, 2021	BUY	$13.71 - $17.18 $4,483 - $5,617	327 Added 16.39%	2,322 $33,000
Q2 2021 Aug 06, 2021	BUY	$14.92 - $23.23 $29,765 - $46,343	1,995 New	1,995 $33,000

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $462M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.